ARCHIVE

• R&D NEWS IN BRIEF
  October 29, 2007

• SEMINAR／Generics to Obtain 1/3 of Market for Antibacterials in 2016: Datamonitor
  October 29, 2007

• Korosho to Increase Multinational Joint Trial Participation Rate under 5-Year Plan
  October 29, 2007

• Consumption of EPO Decreased in 40% of Patients
  October 29, 2007

• OHARA Pharm. Strengthens Product, Information Supply Systems
  October 29, 2007

• Merck Ties UP with ImClone, BMS for Erbitux in Japan
  October 29, 2007

• JGPMA Announces Goals to Promote Use of Generics
  October 29, 2007

• Shionogi's Doripenem Debuts in US Market
  October 29, 2007

• SURVEY／Analysis of Medical Bills Show Increases in Use of Generics: Korosho
  October 29, 2007

• Infection-related Test Market for 2006 Reaches ¥82.5 Bil.: Fuji Keizai
  October 29, 2007

• Action Program Issued by Korosho to Promote Use of Generics
  October 29, 2007

• Kirin Pharma to Merge with Kyowa Hakko
  October 29, 2007

• Korosho Presents List of Issues to Promote Use of Generics to Chuikyo
  October 29, 2007

• More M&As Expected in Japanese Pharma Industry: Mr Eiki
  October 29, 2007

• REGULATORY NEW IN BRIEF
  October 22, 2007

• Nipro Licenses Double-Bag Kit Product to CWP in South Korea
  October 22, 2007

• Main Price Survey to Target Transactions Made in September
  October 22, 2007

• MEDRx Developing Products Using its Innovative DDS Technology
  October 22, 2007

• Business Owners"Burden Is Lighter in Japan than in Other Countries: Mr Hara
  October 22, 2007

• Sanofi-aventis Aims at 31 Submissions by the End of 2010
  October 22, 2007

ページ

• « 先頭
• ‹ Prev
• …
• 310
• 311
• 312
• 313
• 314
• 315
• 316
• 317
• 318
• …
• Next ›
• 最終 »